← Back to Search

Smoking Cessation Counseling for Pregnancy

N/A

Recruiting

Led By Kathryn I Pollak, PhD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥18 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up end-of-pregnancy, up to 45 minutes

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether giving OB clinicians tailored smoking cessation counseling training, in addition to smoking cessation support messages for patients, will help patients quit smoking.

Who is the study for?

This trial is for pregnant women over 18 who smoke and are getting prenatal care from a participating OB clinician. They must have smoked tobacco at their first OB visit, be able to speak and read English, and have access to a cell phone that can send texts.

What is being tested?

The study tests whether combining SMS smoking cessation messages with specialized training for OB clinicians improves quitting rates among pregnant smokers compared to just receiving the messages. Participants will be analyzed based on their quit rates and interactions with clinicians.

What are the potential side effects?

Since this intervention involves communication strategies rather than medications or medical procedures, there are no direct physical side effects expected from participating in this clinical trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ end-of-pregnancy, up to 45 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~end-of-pregnancy, up to 45 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and end-of-pregnancy, up to 45 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of Patients in the Post-Intervention Phase With Validated Cessation

Secondary study objectives

Mean rated autonomy support for each Post-intervention patient

Number of A's performed in the Post-Intervention Phase for each Clinician

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment2 Interventions

Clinicians in the intervention arm will receive a tailored communication training on smoking cessation skills and a general lecture on smoking cessation.

Group II: ControlActive Control1 Intervention

Clinicians in the control arm will be asked to attend a lecture on general information about smoking cessation for pregnant patients and smoking cessation counseling.

0 / 1Eligibility criteria met